1. Nanobiotechnology Market - Market Overview
2. Executive Summary 
3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Nanobiotechnology Market- Market Forces
4.1. Drivers
4.1.1. Development of efficient and advance technology
4.1.2. Technological advancements and rising interest
4.2. Restraints
4.2.1. Higher cost of research and development 
4.3. Opportunities
4.3.1. Emerging economies
4.4. Challenges
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Nanobiotechnology Market- Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Nanobiotechnology Market, By Technology
6.1. Nanocrystals
6.2. Nanoparticles
6.3. Liposomes
6.4. Micelles
6.5. Nanotubes
6.6. others
7. Nanobiotechnology Market, By Application 
7.1. Neurology
7.2. Oncology
7.3. Cardiovascular/physiology
7.4. Anti-inflammatory/immunology
7.5. Anti-infective
7.6. Others
8. Nanobiotechnology Market, By Geography
8.1. Europe
8.1.1. Germany
8.1.2. France
8.1.3. Italy
8.1.4. Spain
8.1.5. Russia
8.1.6. U.K.
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America 
8.3.1. U.S.
8.3.2. Canada
8.3.3. Mexico
8.4. Rest of the World (RoW)
8.4.1. Brazil
8.4.2. Rest of RoW
9. Nanobiotechnology - Market Entropy
9.1. Expansion
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
10.1. AbbVie, Inc
10.2. Amgen, Inc
10.3. Celgene Corporation
10.4. Johnson & Johnson
10.5. Merck & Co., Inc
10.6. Novartis International AG
10.7. 3M company
10.8. AMSC Corporation
10.9. Agilent Technologies Inc
10.10. Bayer AG
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Bibliography
11.5. Compilation of Expert Insights
11.6. Disclaimer